Expensive Life-Saving Drugs: Would £84m-a-year extra cash help?

The NHS could easily afford more life-saving drugs if it just stopped wasting vast amounts of cash on nicotine replacement therapies that don’t work any better than willpower in the long run, as the Borland Report clearly demonstrated in 2005.

Champix Chantix: Alyson and Nick Need Help

The only reason Champix Chantix was passed by the FDA as if it were safe enough to unleash on the public is because the manufacturer, Pfizer, submitted some trial data showing serious side effects “through the wrong channels” which caused them to be missed in a crucial safety review.  Shortly after this news hit the [...]